Opening new frontiers

Research and innovation are the mainstay of Biophore’s operations. The state-of-the-art technology development center located in Hyderabad is equipped with infrastructure that facilitates activities from conceptualization till regulatory approvals and further lifecycle management.

This technology development center has dedicated laboratories for development of peptides, oncology products and other varied therapeutic segments. The research center integrates science with innovation to produce quality products meeting global regulatory standards.

Biophore has filed more than 150 patents across the globe in the areas of processes and polymorphs.

  • R & D Centers

    • 400+ Scientists
    • 80,000 sqft laboratory space
    • Integrated with regulatory and IP
    • Equipped with latest sophisticated instruments
    • Robust quality systems to ensure compliance as per GMP norms


Delivering Excellence

Our manufacturing facilities complement each other in terms of capabilities and are approved by global regulatory authorities, including US FDA and EU.

  • API Unit 1

    • Located in JN Pharma City, Vizag
    • 100% EOU unit, operational since 2010
    • US FDA and EU approved
    • Capacity ranging from very small volumes to high volume products.
    • Also has Oncology manufacturing suite

  • API Unit 2

    • Located in JN Pharma City, Vizag
    • US FDA approved
    • High volume manufacturing capabilities

  • API Unit 3

    • Located in JN Pharma City, Vizag
    • Operational since 2014
    • US FDA approved
    • Dedicated Peptide and Hormonal product manufacturing facilities
    • Lyophilization and dialyzer capabilities

  • API Unit 4

    • Located in JN Pharma City, Vizag
    • Newest manufacturing facility
    • US FDA inspected with zero 483s
    • Multi block facility capable of manufacturing grams to MTs


Non-negotiable compliance

Quality and compliance are the guiding principles of Biophore’s operations. Any activity performed within the organization is bound by our quality framework. Our facilities have a track record of successful audits conducted by authorities from across the globe – US FDA, EMEA, ANVISA, COFEPRIS, WHO GMP among others

Plot#92; 1-98/2/92, Kavuri Hills – Phase II, Jubilee Hills, Hyderabad- 33; Telangana, India